Lupin Receives FDA Approval for Famotidine for Oral Suspension

Thursday, July 1, 2010 General News
Email Print This Page Comment
Font : A-A+

Contact:

Edith St-Hilaire

Director of Marketing

410-576-2000 Ext. 207

esthilaire@lupinusa.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook